Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Dec 2025: the State of Texas sued Epic, alleging an illegal monopoly in electronic health records; Epic calls the suit misguided and faces separate antitrust suits from competitors. Jan 2026: Epic sued Health Gorilla, alleging fraudulent access to about 300,000 patient records.
Sep 2026: Epic disclosed security flaws, found with an AI model, that could let attackers access records undetected, and paused some product development to patch them. No exploitation was reported. NHS DSPT status not yet checked.
Not yet researched.
UK example: East Suffolk and North Essex NHS FT went live in Oct 2025; its Jan 2026 board review reported no system failure and strong MyChart uptake, with the system in stabilisation.
No competitors linked yet.